Sang Hyeon Cheon
Papers
2
Total Citations
17
H-Index
2
About
Dr. Sang Hyeon Cheon is a urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for urologic conditions, particularly renal tumors and prostate cancer. His major contributions include pioneering comparative studies on large angiomyolipomas (AMLs), where he demonstrated that selective arterial embolization (SAE) and nephron-sparing surgery (NSS) using robotic systems yield varying outcomes—a critical insight for tailoring treatment to patient anatomy and tumor size. This work, published in 2021, has garnered 10 citations and informs clinical decision-making for complex renal masses. More recently, Dr. Cheon has been at the forefront of robotic surgery innovation, leading a 2024 study comparing extraperitoneal single-port robot-assisted radical prostatectomy (SP-RARP) with traditional transperitoneal multiport approaches. Using propensity score matching, his research provides early evidence on the feasibility and potential benefits of single-port platforms in confined surgical spaces, a topic of growing interest with 7 citations. By systematically evaluating these novel techniques, Dr. Cheon is shaping the future of urologic oncology, offering patients less invasive options while maintaining oncologic efficacy. His work bridges surgical innovation and evidence-based practice, making him a notable contributor to the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2